[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100553344":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":167,"collaborators":19,"id":169,"slug":170,"hasResults":171,"nctId":172,"briefTitle":173,"officialTitle":174,"acronym":19,"eligibilityCriteria":175,"healthyVolunteers":171,"sex":176,"minAge":177,"maxAge":19,"enrollmentInfo":178,"targetDuration":19,"studyType":181,"phases":182,"briefSummary":184,"conditions":185,"keywords":187,"overallStatus":29,"whyStopped":19,"lastUpdateSubmitDate":188,"lastUpdatePostDateStruct":189,"startDateStruct":192,"completionDateStruct":194,"leadSponsor":196,"locationsCount":179},{"fullName":5,"class":6},"Amryt Pharma","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Metreleptin","EXPERIMENTAL","Metreleptin \\[Recombinant-methionyl human Leptin; r-metHuLeptin\\] for daily injection is a sterile, white, solid lyophilised cake",[13],"Drug: Metreleptin",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","Metreleptin is a recombinant human leptin analog that is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Janet Boylan","CONTACT","+3905212791","clinicaltrials_info@chiesi.com",[27,42,53,61,72,85,97,110,121,132,143,154],{"facility":28,"status":29,"city":30,"state":19,"zip":19,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Centre Hospitalier Régional Universitaire de Lille (CHRU) - Hôpital Claude Huriez","RECRUITING","Lille","France","FR",{"type":34,"coordinates":35},"Point",[36,37],3.05512,50.63391,{"lat":37,"lon":36},[40],{"name":41,"role":23,"phone":19,"phoneExt":19,"email":19},"Marie-Christine Vantyghem",{"facility":43,"status":29,"city":44,"state":19,"zip":19,"country":31,"countryCode":32,"cosmosGeoPoint":45,"geoPoint":49,"contacts":50},"Hopital Pitie-Salpetriere","Paris",{"type":34,"coordinates":46},[47,48],2.3488,48.85341,{"lat":48,"lon":47},[51],{"name":52,"role":23,"phone":19,"phoneExt":19,"email":19},"Fabrizio Andreelli",{"facility":54,"status":29,"city":44,"state":19,"zip":19,"country":31,"countryCode":32,"cosmosGeoPoint":55,"geoPoint":57,"contacts":58},"Hôpital Saint-Antoine",{"type":34,"coordinates":56},[47,48],{"lat":48,"lon":47},[59],{"name":60,"role":23,"phone":19,"phoneExt":19,"email":19},"Corinne Vigouroux",{"facility":62,"status":29,"city":63,"state":19,"zip":19,"country":31,"countryCode":32,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"Centre Hospitalier Lyon-Sud","Pierre-Bénite",{"type":34,"coordinates":65},[66,67],4.82424,45.70359,{"lat":67,"lon":66},[70],{"name":71,"role":23,"phone":19,"phoneExt":19,"email":19},"Emmanuel Disse",{"facility":73,"status":29,"city":74,"state":19,"zip":19,"country":75,"countryCode":76,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Charite-Universitaetsmedizin Berlin - Campus Charite Mitte (CCM)","Berlin","Germany","DE",{"type":34,"coordinates":78},[79,80],13.41053,52.52437,{"lat":80,"lon":79},[83],{"name":84,"role":23,"phone":19,"phoneExt":19,"email":19},"Thomas Bobbert",{"facility":86,"status":87,"city":88,"state":19,"zip":19,"country":75,"countryCode":76,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"Universitaetsklinikum Ulm - Klinik fuer Kinder- und Jugendmedizin","NOT_YET_RECRUITING","Ulm",{"type":34,"coordinates":90},[91,92],9.99155,48.39841,{"lat":92,"lon":91},[95],{"name":96,"role":23,"phone":19,"phoneExt":19,"email":19},"Martin Wabitsch",{"facility":98,"status":29,"city":99,"state":19,"zip":19,"country":100,"countryCode":101,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi","Bologna","Italy","IT",{"type":34,"coordinates":103},[104,105],11.33875,44.49381,{"lat":105,"lon":104},[108],{"name":109,"role":23,"phone":19,"phoneExt":19,"email":19},"Alessandra Gambineri",{"facility":111,"status":87,"city":112,"state":19,"zip":19,"country":100,"countryCode":101,"cosmosGeoPoint":113,"geoPoint":117,"contacts":118},"Universitá degli Studi \"Magna Graecia\" di Catanzaro","Catanzaro",{"type":34,"coordinates":114},[115,116],16.60086,38.88247,{"lat":116,"lon":115},[119],{"name":120,"role":23,"phone":19,"phoneExt":19,"email":19},"Antonio Aversa",{"facility":122,"status":29,"city":123,"state":19,"zip":19,"country":100,"countryCode":101,"cosmosGeoPoint":124,"geoPoint":128,"contacts":129},"Azienda Ospedaliero Universitaria Maggiore della Carità di Novara","Novara",{"type":34,"coordinates":125},[126,127],8.62118,45.44694,{"lat":127,"lon":126},[130],{"name":131,"role":23,"phone":19,"phoneExt":19,"email":19},"Flavia Prodam",{"facility":133,"status":29,"city":134,"state":19,"zip":19,"country":100,"countryCode":101,"cosmosGeoPoint":135,"geoPoint":139,"contacts":140},"Azienda Ospedaliero Universitaria Pisana - Stabilimento di Cisanello","Pisa",{"type":34,"coordinates":136},[137,138],10.4036,43.70853,{"lat":138,"lon":137},[141],{"name":142,"role":23,"phone":19,"phoneExt":19,"email":19},"Giovanni Ceccarini",{"facility":144,"status":29,"city":145,"state":19,"zip":19,"country":100,"countryCode":101,"cosmosGeoPoint":146,"geoPoint":150,"contacts":151},"A.S.U Integrata di Udine - Presidio Ospedaliero Santa Maria della Misericordia","Udine",{"type":34,"coordinates":147},[148,149],13.23715,46.0693,{"lat":149,"lon":148},[152],{"name":153,"role":23,"phone":19,"phoneExt":19,"email":19},"Annalisa Sechi",{"facility":155,"status":87,"city":156,"state":19,"zip":19,"country":157,"countryCode":158,"cosmosGeoPoint":159,"geoPoint":163,"contacts":164},"Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital","Cambridge","United Kingdom","UK",{"type":34,"coordinates":160},[161,162],0.11667,52.2,{"lat":162,"lon":161},[165],{"name":166,"role":23,"phone":19,"phoneExt":19,"email":19},"Anna Stears",{"type":168,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100553344","phase-4-open-label-study-to-evaluate-metreleptin-in-patients-with-partial-lipodystrophy-100553344",false,"NCT06484868","Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy","A 24-Month, Multi-Centre, Open Label Phase IV Post Authorisation Efficacy Study to Evaluate the Efficacy, Safety and Immunogenicity of Daily Subcutaneous Metreleptin Treatment in Patients With Partial Lipodystrophy","Inclusion Criteria:\n\n* Confirmed diagnosis of familial or acquired partial lipodystrophy\n\nExclusion Criteria:\n\n* Treatment with any Investigational Medicinal Product (IMP) within 6 months or 5 times the terminal half-life of the corresponding IMP, whichever is longer, before the screening visit.\n\nOther protocol defined inclusion\u002Fexclusion criteria apply","ALL","12 Years",{"count":179,"type":180},12,"ESTIMATED","INTERVENTIONAL",[183],"PHASE4","This is an Open Label, Phase IV, Post Authorisation Study to Evaluate the Efficacy, Safety and Immunogenicity of Daily Subcutaneous Metreleptin Treatment in people with Partial Lipodystrophy",[186],"Partial Lipodystrophy",[9],"2025-07-02",{"date":190,"type":191},"2025-07-03","ACTUAL",{"date":193,"type":191},"2024-02-08",{"date":195,"type":180},"2028-02",{"name":5,"class":6}]